Salesforce (CRM) stock is trading at $151.67, just above its 52-week low of $149.80, after falling 41% so far in 2026. That makes it the second-worst performer in Monness, Crespi, Hardt’s coverage universe.
On Wednesday, Monness upgraded CRM from Neutral to Buy and set a price target of $200. The firm called the valuation compelling given the scale of the decline.
Salesforce is now 58% off its all-time high hit in late 2024. The stock was trading at $155.02 at the time of the rating change and has slipped further since.
The numbers back up the value case. CRM trades at a P/E of 18.1 and a PEG ratio of 0.47. The company carries a gross profit margin of 77.6% and a free cash flow yield of 12%.
Monness also pointed to Salesforce’s cash flow generation, margin profile, and its $25 billion stock buyback program — authorized in March — as reasons to feel more comfortable stepping in here.
Salesforce recently agreed to buy Fin, formerly known as Intercom, for $3.6 billion in cash. Fin’s AI agent product autonomously resolves customer queries with a 76% resolution rate and generates over $400 million in annual recurring revenue.
Several analyst firms responded positively to the deal. Jefferies kept its Buy rating and $250 target. Canaccord Genuity reiterated Buy at $225. Stifel held its Buy and $250 target. Wolfe Research kept its Outperform rating with a $220 target.
UBS was the outlier, holding a Neutral rating with a $185 price target and a more cautious view on the acquisition’s near-term impact.
In its most recent quarter, reported May 27, Salesforce posted EPS of $3.88, beating the consensus estimate of $3.13 by $0.75. Revenue came in at $11.13 billion, ahead of the $11.05 billion estimate, and up 13.3% year-over-year.
The company set FY2027 EPS guidance at $14.06–$14.12 and Q2 2027 guidance at $3.25–$3.27. Analysts on average expect full-year EPS of $10.29.
Institutional investors remain active. SG Trading Solutions opened a new position worth roughly $1.18 million. Temasek, Fisher Asset Management, and Van Eck Associates all added to existing positions. Institutions and hedge funds now hold 80.43% of CRM.
The average analyst price target sits at $257.61. Of 42 analysts covering the stock, 26 have Buy ratings, 12 Hold, and 3 Sell. One has a Strong Buy.
The company also declared a quarterly dividend of $0.44 per share, payable July 2, with an annualized yield of 1.2%.
CRM’s 50-day moving average is $177.91. Its 200-day moving average is $204.72, both well above where the stock is trading today.
The post Salesforce (CRM) Stock Down 41% in 2026 — Is Now the Time to Buy? appeared first on CoinCentral.
